Efficacy of probiotics and nutrients in functional gastrointestinal disorders: A preliminary clinical trial

Digestive Diseases and Sciences

Volumn 51, Issue 12, 2006, Pages 2134-2144

  Kim, Linda S ^a   Hilli, Lisa ^a   Orlowski, Jennifer ^a   Kupperman, Jami L ^a   Baral, Matthew ^a   Waters, Robert F ^a  

^a Southwest College Naturopathic Med   (United States)

Author keywords

Clinical trial; Dietary supplements; Functional gastrointestinal disorders; Probiotics

Indexed keywords

INDICAN; PLANT EXTRACT; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; MIDDLE AGED; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PILOT STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; URINE;

ABDOMINAL PAIN; ADULT; AGED; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INDICAN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PILOT PROJECTS; PLANT EXTRACTS; PROBIOTICS; QUALITY OF LIFE;

EID: 33846946465     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-006-9297-8     Document Type: Article

References (73)

1. Drossman DA (1995) Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 123:688-697
2. Hyams JS (1999) Functional gastrointestinal disorders. Curr Opin Pediatr 11:375-378
3. Pare P (1999) Systematic approach toward the clinical diagnosis of functional dyspepsia. Can J Gastroenterol 13:647-654
4. Drossman DA (1999) The functional gastrointestinal disorders and the Rome II process. Gut 45(Suppl 2):1-5
5. Drossman DA, Li Z, Andruzzi E, et al. (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38:1569-1580
6. Glise H, Wiklund I, Hallerback B (1998) Burden of illness in functional gastrointestinal disorder - the consequences for the individual and society. Eur J Surg Suppl:67-72
7. Drossman DA (2000) The functional gastrointestinal disorders. 2nd ed. Degnon Associates, McLean, VA
8. Hollander D (1999) Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1:410-416
9. Madara JL (1990) Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am J Pathol 137:1273-1281
10. Ballard ST, Hunter JH, Taylor AE (1995) Regulation of tightjunction permeability during nutrient absorption across the intestinal epithelium. Annu Rev Nutr 15:35-55
11. Bjarnason I (1994) Intestinal permeability. Gut 35:S18-S22
12. Sanderson IR, Walker WA (1993) Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 104:622-639
13. Ahmed T, Fuchs GJ (1997) Gastrointestinal allergy to food: a review. J Diarrhoeal Dis Res 15:211-223
14. Knutson TW, Bengtsson U, Dannaeus A, Ahlstedt S, Knutson L (1996) Effects of luminal antigen on intestinal albumin and hyaluronan permeability and ion transport in atopic patients. J Allergy Clin Immunol 97:1225-1232
15. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A,Michaelsen KF (2004) Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 145:612-616
16. Hijazi Z, Molla AM, Al-Habashi H, Muawad WM, Molla AM, Sharma PN (2004) Intestinal permeability is increased in bronchial asthma. Arch Dis Child 89:227-229
17. Johnston SD, Smye M, Watson RG, McMillan SA, Trimble ER, Love AH (2000) Lactulose-mannitol intestinal permeability test: a useful screening test for adult coeliac disease. Ann Clin Biochem 37(Pt 4):512-519
18. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, Venturi C, Longo G, Sturniolo GC(1999) Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 94:2956-2960
19. Shorter RG, Huizenga KA, Spencer RJ (1972) A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis 17:1024-1032
20. Uil JJ, van Elburg RM, van Overbeek FM, Mulder CJ, VanBerge-Henegouwen GP, Heymans HS (1997) Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function. Scand J Gastroenterol Suppl 223:70-78
21. Di Leo V, D'Inca R, Diaz-Granado N, Fries W, Venturi C, D'Odorico A, Martines D, Sturniolo GC (2003) Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea. Am J Gastroenterol 98:2245-2252
22. Curzon G, Walsh J (1966) Value of measuring urinary indicant excretion. Gut 7:711
23. Greenberger NJ, Saegh S, Ruppert RD (1968) Urine indican excretion in malabsorptive disorders. Gastroenterology 55:204-211
24. Thompson WG, Longstreth GF, Drossman DA, HeatonKW, Irvine EJ, Muller-LissnerSA(1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43-II47
25. Bovee-Oudenhoven I, Termont D, Dekker R, Van der Meer R (1996) Calcium in milk and fermentation by yoghurt bacteria increase the resistance of rats to Salmonella infection. Gut 38:59-65
26. HirabayashiM,Matsui T, Yano H (1998) Fermentation of soybean flour with Aspergillus usamii improves availabilities of zinc and iron in rats. J Nutr Sci Vitaminol (Tokyo) 44:877-886
27. Kollist-Siigur K, Nielsen T, Gron C, Hansen PE, Helweg C, Jonassen KE, Jorgensen O, Kirso U (2001) Sorption of polycyclic aromatic compounds to humic and fulvic acid HPLC column materials. J Environ Qual 30:526-537
28. Hertkorn N, Permin A, Perminova I, Kovalevskii D, Yudov M, Petrosyan V, Kettrup A (2002) Comparative analysis of partial structures of a peat humic and fulvic acid using one- and twodimensional nuclear magnetic resonance spectroscopy. J Environ Qual 31:375-387
29. Kailasapathy K, Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78:80-88
30. Tannock GW (2002) The bifidobacterial and Lactobacillus microflora of humans. Clin Rev Allergy Immunol 22:231-253
31. Periti P, Tonelli F (2001) Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii. J Chemother 13:473-493
32. Sanders ME, Morelli L, Tompkins TA (2003) Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comp Rev Food Sci Food Safety 2:101-110
33. Sanders ME, Morelli L, Bush S (2001) "Lactobacillus sporogenes" is not a Lactobacillus probiotic. Am Soc Microbiol News 67:385-386
34. Nakamura LK, Blumenstock I, Claus D (1988) Taxonomic study of Bacillus coagulans Hammer 1915 with a proposal for Bacillus smithii sp. Int J Syst Evol Microbiol 38:63-73
35. Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, Ricca E, Cutting AS (2000) Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl EnvironMicrobiol 66:5241-5247
36. Hosoi T, Ametani A, Kiuchi K, Kaminogawa S (2000) Improved growth and viability of lactobacilli in the presence of Bacillus subtilis (natto), catalase, or subtilisin. Can J Microbiol 46:892-897
37. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Megraud F, Urdaci MC (2001) In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45:3156-3161
38. Eypasch E,Williams JI,Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H (1995) Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 82:216-222
39. Bergmann JF, Chassany O (1998) The role of quality of life in functional gastrointestinal disorders: regulatory issues. Eur J Surg Suppl:87-91
40. Damiano A, Handley K, Adler E, Siddique R, Bhattacharyja A (2002) Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS). Dig Dis Sci 47:1530-1537
41. Floch MH, Hong-Curtiss J (2002) Probiotics and functional foods in gastrointestinal disorders. Curr Treat Options Gastroenterol 5:311-321
42. Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila-Sandholm T (2002) Gut bacteria and health foods - the European perspective. Int J Food Microbiol 78:99-117
43. Young RJ, Huffman S (2003) Probiotic use in children. J Pediatr Health Care 17:277-283
44. Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73:1142S-1146S
45. Kirjavainen PV, Gibson GR (1999) Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 31:288-292
46. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076-1079
47. Laiho K, Ouwehand A, Salminen S, Isolauri E (2002) Inventing probiotic functional foods for patients with allergic disease. Ann Allergy Asthma Immunol 89:75-82
48. Vanderhoof JA, Young RJ (2003) Role of probiotics in the management of patients with food allergy. Ann Allergy Asthma Immunol 90:99-103
49. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR (2003) A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 17:895-904
50. Madden JA, Hunter JO (2002) A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 88(Suppl 1):S67-S72
51. Saggioro A (2004) Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 38:S104-S106
52. KruisW, Fric P, Pokrotnieks J, LukasM, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53:1617-1623
53. Alvarez-Olmos MI, Oberhelman RA (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32:1567-1576
54. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J (2004) Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 7:59-62
55. Teitelbaum JE, Walker WA (2002) Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 22:107-138
56. Brown AC, Valiere A (2004) Probiotics and medical nutrition therapy. Nutr Clin Care 7:56-68
57. Fioramonti J, Theodorou V, Bueno L (2003) Probiotics: what are they?What are their effects on gut physiology? Best Pract Res Clin Gastroenterol 17:711-724
58. Miraglia del Giudice M, De LucaMG(2004) The role of probiotics in the clinical management of food allergy and atopic dermatitis. J Clin Gastroenterol 38:S84-S85
59. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, Rossmann P, Bartova J, Sokol D, Funda DP, Borovska D, Rehakova Z, Sinkora J, Hofman J, Drastich P, Kokesova A (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93:97-108
60. Duggan C, Gannon J, Walker WA (2002) Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 75:789-808
61. Johnson IT (2001) New food components and gastrointestinal health. Proc Nutr Soc 60:481-488
62. Roberfroid M (2002) Functional food concept and its application to prebiotics. Dig Liver Dis 34(Suppl 2):S105-S110
63. Holzapfel WH, Haberer P, Geisen R, Bjorkroth J, Schillinger U (2001) Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73:365S-373S
64. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S (2001) Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 73:393S-398S
65. Cucchiara S, Falconieri P, Di Nardo G, Parcelii MA, Dito L, GrandinettiA(2002) Newtherapeutic approach in themanagement of intestinal disease: probiotics in intestinal disease in paediatric age. Dig Liver Dis 34(Suppl 2):S44-S47
66. Mombelli B, Gismondo MR (2000) The use of probiotics in medical practice. Int J Antimicrob Agents 16:531-536
67. von der Weid T, Ibnou-Zekri N, Pfeifer A (2002) Novel probiotics for the management of allergic inflammation. Dig Liver Dis 34(Suppl 2):S25-S28
68. Cross ML (2004) Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int J Immunopathol Pharmacol 17:127-134
69. Fedorak RN, Madsen KL (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20:146-155
70. Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC (2004) Monostrain, multistrain and multispecies probiotics - a comparison of functionality and efficacy. Int J Food Microbiol 96:219-233
71. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128:541-551
72. Vogelsang H, Schwarzenhofer M, Oberhuber G (1998) Changes in gastrointestinal permeability in celiac disease. Dig Dis 16:333-336
73. Wyatt J, Oberhuber G, Pongratz S, Puspok A, Moser G, Novacek G, Lochs H, Vogelsang H (1997) Increased gastric and intestinal permeability in patients with Crohn's disease. Am J Gastroenterol 92:1891-1896